ACM
PDSB icon

AIGH Capital Management’s PDS Biotechnology PDSB Stock Holding History

AIGH Capital Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-282,609
Closed -$1.75M – 54
2022
Q1 		$1.75M Sell
282,609
-25,425
-8% -$158K 0.43% 30
2021
Q4 		$2.5M Sell
308,034
-465,526
-60% -$5.01M 0.76% 31
2021
Q3 		$11.5M Sell
773,560
-725,589
-48% -$9.05M 2.42% 15
2021
Q2 		$18.8M Buy
+1,499,149
New +$11.7M 3.39% 6

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AIGH Capital Management's PDSB Position: Q2 2022 in Review

AIGH Capital Management sold out of PDS Biotechnology (PDSB) in Q2 2022, closing a stake of 282,609 shares — an estimated $1.75M sold.

AIGH Capital Management first reported a position in PDSB in Q2 2021 and held it in 4 quarters. The position peaked at $18.8M in Q2 2021. 51 funds tracked by Wall St. Rank hold PDSB as of Q2 2022.

  • AIGH Capital Management reported no remaining PDS Biotechnology position as of Q2 2022 after selling out during the quarter.
  • AIGH Capital Management sold 282,609 PDS Biotechnology shares in Q2 2022, an estimated $1.75M.
  • AIGH Capital Management first reported a position in PDS Biotechnology in Q2 2021 and held it in 4 quarters.
  • AIGH Capital Management's PDS Biotechnology position peaked at $18.8M in Q2 2021.
  • 51 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2022.

Based on AIGH Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.